The most efficient regimens are broadly separated into these sub-types: acute leukemia treatment (AML or ALL-like), lymphoma-like treatment, and asparaginase/methotrexate-based treatments that are also used in aggressive leukemias and lymphomas. Here, ASPG is linked to acute lymphoblastic leukemia.